CDH2 and breast cancer: It has been shown that CD44s expression levels are associated with the mesenchymal phenotype in breast cancer [25, 31] and hepatocellular carcinoma [32], and has been implicated in promoting EMT, evidenced by decreased E-cadherin expression and increased N-cadherin and Vimentin expression [25].